AIM

#4754
AIM ImmunoTech Inc. Common Stock
0.3 9 USD
-7.14%
Sektör: Sağlık Hizmetleri
Baz: USD
Kar Para Birimi: USD
Günlük Aralık
0.39
0.39
Yıllık Aralık
0.21
20.35
Günlük Değişim
-7.14%
Aylık Değişim
-23.54%
6 Aylık Değişim
-75.65%
Yıllık Değişim
-95.41%
Önceki Kapanış
0.4 2
Open
0.3 9
Düşük
0.3 9
High
0.3 9
Hacim
233
Tam grafiği aç Full chart

Financials

Genel Bakış Tablolar İstatistikler
Çeyreklik Yıllık
  • Market Capitalization 5.68 M
  • Employee 21
  • Founded N/A
  • CEO N/A
  • Website www.aimimmuno.com
  • Headquarter Delaware, United States
  • FIGI BBG000JL6Z80
  • Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-0.13
Fiyat/satışlar oranı
20.76

AIM ImmunoTech Inc. Common Stock

AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is a biopharmaceutical company based in Ocala, Florida that is focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Founded in 1990, the company has twenty-three employees. The company has created an immunomodulatory double stranded RNA drug called Ampligen. It is also developing Ampligen to use as a treatment for multiple cancer tumor types, COVID-19 and chronic fatigue syndrome.

Haberler